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Abstract
Background: Establishing the underlying cause of anaemia in general practice is a diagnostic challenge. Currently,
general practitioners individually determine which laboratory tests to request (routine work-up) in order to diagnose
the underlying cause. However, an extensive work-up (consisting of 14 tests) increases the proportion of patients
correctly diagnosed. This study investigates the cost-effectiveness of this extensive work-up.
Methods: A decision-analytic model was developed, incorporating all societal costs from the moment a patient presents
to a general practitioner with symptoms suggestive of anaemia (aged5 50 years), until the patient was (correctly)
diagnosed and treated in primary care, or referred to (and diagnosed in) secondary care. Model inputs were derived
from an online survey among general practitioners, expert estimates and published data. The primary outcome measure
was expressed as incremental cost per additional patient diagnosed with the correct underlying cause of anaemia in
either work-up.
Results: The probability of general practitioners diagnosing the correct underlying cause increased from 49.6% (95% CI:
44.8% to 54.5%) in the routine work-up to 56.0% (95% CI: 51.2% to 60.8%) in the extensive work-up (i.e. þ6.4% [95% CI:
0.6% to 13.1%]). Costs are expected to increase slightly from E842/patient (95% CI: E704 to E994) to E845/patient
(95% CI: E711 to E994), i.e. þE3/patient (95% CI: E35 to E40) in the extensive work-up, indicating incremental costs
of E43 per additional patient correctly diagnosed.
Conclusions: The extensive laboratory work-up is more effective for diagnosing the underlying cause of anaemia by
general practitioners, at a minimal increase in costs. As accompanying benefits in terms of quality of life and reduced
productivity losses could not be captured in this analysis, the extensive work-up is likely cost-effective.
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Background
Anaemia is a common medical problem that
carries substantial costs to the healthcare system and
can be a burden on the health and quality of life
of many individuals.1–10 Therefore, adequate diagnosis
and early initiation of correct treatment are essential.11
However, anaemia is not a disease in itself, but is
considered a sign of an underlying condition.
Consequently, diagnosing the underlying cause of anae-
mia is often complex.12–14 More speciﬁcally, previous
research estimated that in 14–33% of older persons
with anaemia, the underlying cause is unknown.1,12 In
addition, anaemia is often under-diagnosed15 and
under-treated, as it is often considered a consequence
of aging12 and not as a speciﬁc symptom of disease.
The three most common underlying causes are: iron
deﬁciency anaemia (IDA), anaemia of chronic disease
(ACD) and renal anaemia.16 Anaemia may also have a
variety of other causes, including bone marrow diseases
or vitamin deﬁciencies, such as B12 and/or folic acid.
Besides anamnesis and physical examination, labora-
tory analyses are required to identify the diﬀerent
underlying causes of anaemia. However, depending on
the laboratory protocol used, the proportion of patients
for whom no underlying cause of anaemia can be iden-
tiﬁed based on their laboratory analyses ranges from
28% to 52%.17 In order to enhance the eﬀectiveness of
laboratory analyses, a guideline has been developed by
the Dutch College of General Practitioners (DCGP).18
Previous research evaluated all laboratory tests of
patients (women> 50 years and men5 18 years) with
anaemia newly diagnosed by general practitioners
(GPs) within a two-year time period. Unfortunately,
83.9% of those patients could not be diagnosed when
applying the DCGP-guideline, because at least one of
the required laboratory tests had not been performed.11
In a recently performed study, we investigated
whether an extensive laboratory work-up (consisting
of a set of 14 tests) could increase the probability that
patients are diagnosed with the correct underlying
cause of anaemia in Dutch general practice.19
Although this study has shown that this work-up
likely improves the probability that patients are cor-
rectly diagnosed with the underlying cause of anaemia,
it is unknown whether this approach is cost-eﬀective.
In addition, even though most routine laboratory tests
for diagnosing anaemia are relatively inexpensive, these
test results will likely impact subsequent patient man-
agement decisions. As this may involve more expensive
diagnostic testing and the referral of patients to second-
ary care, it is crucial to quantify the impact of such an
extensive laboratory work-up further downstream the
patient management pathway. Therefore, the current
study aims to estimate the cost-eﬀectiveness of this
extensive laboratory work-up as compared with the
current situation, the routine work-up, in which GPs
decide for themselves which tests to request in patients
presenting with symptoms of anaemia.
Methods
Survey
The eﬀectiveness of diagnosing the underlying cause of
anaemia in general practice, using either the extensive or
a routine work-up, was investigated through an online
survey using LimeSurvey.20 A full description of this
survey is provided elsewhere.19 Details on how this
survey was distributed are provided in Supplemental
Data 1. In the survey, all participating GPs (139 out of
836, i.e. 16.6%) received six real-world cases of patients
presenting with a new anaemia in general practice. In all
six cases, the participating GPs were only provided with
the age and gender of the patient and were informed that
the patient was suspected of anaemia. In the ﬁrst three
cases, GPs were able to choose freely which tests they
would request based on a predeﬁned list of 14 common
tests (haemoglobin, mean corpuscular volume [MCV],
C-reactive protein [CRP] and/or erythrocyte sedimenta-
tion rate [ESR], vitamin B12, creatinine, ferritin, folic
acid, lactate dehydrogenase [LDH], transferrin, reticulo-
cytes, leukocytes, thrombocytes and serum iron) and
were only given the results of the tests they selected. In
the second set of three cases, GPs received the results of
all 14 tests. In all six cases, the GPs were asked to choose
between IDA, ACD, renal anaemia and ‘other’. In cases
where the GPs chose ‘other’, they were asked to specify
the underlying cause of anaemia. GPs could also state
that the cause was ‘unknown’, if they did not consider it
possible to determine the underlying cause based on the
laboratory results provided. Besides, the GPs were also
asked which of the subsequent actions they would take
in each case: close the consultation (i.e. do nothing),
refer the patient to secondary care, prescribe medication
(which involved prescribing iron, vitamin B12, folic acid
or antibiotics), or see the patient again in a few weeks
(follow-up). During the survey, the GPs were encour-
aged to use guidelines (e.g. the DCGP guideline) or
other tools they use in daily practice.
Database used in the survey
A detailed explanation regarding how the cases used in
the survey were obtained from this database has been
described previously.19
Health economic model
As health economic models are typically complex, a
description of the main aspects regarding model
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structure and model inputs is provided below. A more
extensive description, including the assumptions used,
is provided in Supplemental Data 1.
A decision tree was developed to estimate the
cost-eﬀectiveness of an extensive laboratory work-up
compared with a routine work-up in diagnosing the
underlying cause of anaemia in patients presenting
with anaemia, aged5 50 years, in Dutch general prac-
tice. A simpliﬁed version is shown in Figure 1. The
correct underlying cause of anaemia was determined
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work-up*† ‡
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Right 
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Prescribe medicaon† ‡
Referral‡
Follow-up‡
Close consultaon‡
Prescribe medicaon† ‡
Referral‡
Follow-up‡
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Prescribe medicaon† ‡
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Prescribe medicaon† ‡
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Prescribe medicaon† ‡
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Follow-up‡
Figure 1. Simplified decision tree demonstrating both laboratory work-ups (routine and extensive) of patients presenting with new
anaemia in general practices.
*The structure of this decision tree is identical to the routine work-up, but differs in the probabilities that are used. The structure of
the entire decision tree could not be shown due to lack of space.
yIn patients prescribed medication, the GPs chose to prescribe iron, vitamin B12, folic acid, or antibiotics.
zPatients whom initially received a treatment that is ineffective (according to the expert panel), either have recover spontaneously, or
are assumed to present at the GP again within a few weeks, and undergo a second round of diagnostics and treatment. In this second
round, it is assumed that GPs will only make management decisions that are considered effective (medication or referral, depending on
the underlying cause of anaemia).
ACD: anaemia of chronic disease; GP: general practitioner; IDA: iron deficiency anaemia.
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according to an expert panel, composed of an internist,
a GP and a clinical chemist. Incremental eﬀect was
deﬁned as the diﬀerence in the percentage of patients
for whom the underlying cause of anaemia was cor-
rectly determined using a routine laboratory work-up
(i.e. current practice) as compared with the extensive
work-up. According to Dutch health economic guide-
lines, a societal perspective was taken in the cost-eﬀec-
tiveness analysis.21 This means that all costs were
included from the moment such a patient presents at
the GP, until the patient is (correctly) diagnosed and
treated in primary care, or referred to (and diagnosed
in) secondary care. As the treatment of anaemia in sec-
ondary care strongly varies depending on its underlying
cause, quantifying the impact of either work-up on
patients’ quality of life would require extensive individ-
ual patient-level data, which were not available. As
such, this was considered outside the scope of this
analysis. The time horizon in this study was therefore
estimated to be, at most, 200 days. Incremental cost
was deﬁned as the diﬀerence in average costs per
patient for whom the underlying cause of anaemia
was determined using the extensive work-up as com-
pared with the routine work-up. Costs were expressed
in 2016 Euros. The model outcome was expressed as an
incremental cost-eﬀectiveness ratio (ICER), represent-
ing the incremental costs per additional patient diag-
nosed with the correct underlying cause of anaemia.
To obtain further insight as to testing for which under-
lying causes of anaemia (i.e. IDA, ACD, renal anaemia
and ‘other’) potentially has the most room for improve-
ment in terms of cost-eﬀectiveness, subgroup analyses
were performed.
Model inputs
The incidence of the diﬀerent underlying causes of anae-
mia in Dutch patients aged5 50 years, was based on the
abovementioned database.16 The results of the survey
were used to calculate the probability that the right under-
lying cause of anaemia (according to the expert panel)
was established within each of those patient categories,
for both work-ups. The likelihoods that GPs chose a cer-
tain type of treatment based on the diﬀerent underlying
causes of anaemia (i.e. prescribe medication (including
the type of medication), refer the patient to secondary
care, perform follow-up of the patient or to close the con-
sultation without performing additional actions) were
also derived from this survey. In cases where the GP
decided to hold a follow-up appointment with the patient
or to close the consultation, the probability of spontan-
eous recovery of a patient’s anaemia was taken into
account for each of the diﬀerent underlying causes. A
detailed overview of the model structure, input
parameters and the assumptions used is provided in
Supplemental Data 1. Values for input parameters that
could not be obtained from literature, such as the dur-
ation of oral iron supplementation, were derived from
expert elicitations with two internist-haematologists
(Supplemental Data 1).
Probabilistic sensitivity analyses
Random samples were simultaneously drawn for all
input parameters based on predeﬁned parameter distri-
butions. Distributions were parameterized based on the
observed parameter mean and on the observed or
assumed standard error (Supplemental Data 1).
To determine the eﬀect of joint uncertainty in all
input parameters on model outcomes, a probabilistic
sensitivity analysis (PSA) was performed based on a
Monte Carlo simulation with 10,000 samples.
One-way sensitivity analysis
To identify which individual parameters substantially
inﬂuence model outcomes, a one-way deterministic sen-
sitivity analysis was conducted. For each parameter,
the impact on total costs per patient resulting from a
change from the base case value to the lower and to the
upper limit for the corresponding 95% conﬁdence inter-
val was analysed. A detailed overview of the inputs
used in the one-way sensitivity analysis is provided in
Supplemental Data 1.
Results
Overall cost-effectiveness
As shown in Table 1, the routine laboratory work-up
costs E842 (95% CI: E704 to E994) per patient,
as compared with E845 (95% CI: E711 to E994) for
the extensive laboratory work-up (an increase of E3 per
patient [95% CI: E35 to E40], i.e. þ0.3%). Compared
with the routine work-up, the extensive work-up
showed a trend of an increase in the percentage of
patients diagnosed with the correct underlying condi-
tion of anaemia from 49.6% (95% CI: 44.8% to 54.5%)
to 56.0% (95% CI: 51.2% to 60.8%), i.e. þ6.4% (95%
CI: 0.6% to 13.1%). This resulted in an ICER of E43
per additional patient diagnosed with the correct
underlying cause of anaemia. Estimating that 57,000
patients aged5 50 years present with a new anaemia
in Dutch general practices annually (i.e. no anaemia in
preceding two years),22,23 this can result in an increase
of around 3600 patients who are diagnosed both earlier
and with the correct underlying cause of anaemia, at an
additional cost of E156,000/year.
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Diagnosis-specific cost-effectiveness
The results of subgroup analyses indicated that average
per patient costs were expected to increase by E28
(95% CI: E62 to E120) among IDA patients and
by E34 (95% CI: E25 to E90) among ACD patients.
In contrast, among renal anaemia patients and patients
with ‘other’ underlying causes of anaemia, those costs
are expected to decrease by E82 (95% CI: E193 to
E26) and by E11 (95% CI: E71 to E49), respectively.
The percentage of patients for whom the correct under-
lying cause is established is expected to increase by
0.9% (95% CI: 14.8% to 16.4%) among IDA
patients, by 10.1% (95% CI: 2.0% to 22.1%)
among ACD patients, by 12.4% (95% CI: 6.8% to
31.2%) among renal anaemia patients and by 4.3%
(95% CI: 6.8% to 15.1%) among patients with
‘other’ underlying causes. Table 1 shows a detailed
overview of all model outcomes, sorted by underlying
cause of anaemia. The incremental cost-eﬀectiveness
plane demonstrating the overall result of 10,000
model simulations is shown in Figure 2. This ﬁgure
indicates that 44.2% of the model simulations resulted
in lower total costs of the extensive work-up as com-
pared with the routine work-up. The incremental cost-
eﬀectiveness plane for the subgroups of anaemia
patients (i.e. IDA, ACD, renal anaemia and ‘other’) is
shown in Supplemental Data 1. The impact of separ-
ately inserting the inputs of the internist-haematologists
on model outcomes as opposed to using their averaged
estimates (as in the base case analysis) was considered
negligible (Supplemental Data 1). In addition, 56.2%
of the model simulations indicated lower costs in
the extensive work-up (data not shown), when only
considering costs of the initial GP consultation and
accompanying phlebotomy and laboratory analyses
(with a maximum of requesting laboratory tests twice
in the routine work-up).
One-way sensitivity analysis
In Figure 3, the results of one-way sensitivity analyses
are shown for the 10 parameters with the highest
impact on the diﬀerence in costs. The diﬀerence in
costs between both strategies was found to be most
sensitive to changes in the frequency with which GPs
correctly diagnose the underlying cause of anaemia, in
both the extensive and the routine work-ups. The costs
per GP consultation and the probability of spontan-
eous recovery of ACD have the highest impact on the
diﬀerence in costs between both work-ups.
Conclusion and discussion
The use of an extensive laboratory work-up likely
increases the percentage of patients diagnosed with
the correct underlying cause of anaemia as compared
with the routine work-up. Simultaneously, a very minor
-€ 40 -€ 30 -€ 20 -€ 10 € 0 € 10 € 20 € 30 € 40
Probability spontaneous recovery ACD
Probability right diagnosis RA - extensive work-up
Probability right diagnosis RA - roune work-up
Probability right diagnosis ACD - roune work-up
Costs per GP consultaon
Probability right diagnosis IDA - extensive work-up
Probability right diagnosis IDA - roune work-up
Probability right diagnosis ACD - extensive work-up
Probability right diagnosis 'other' - extensive work-up
Probability right diagnosis 'other' - roune work-up
Impact on the diﬀerence in costs between the extensive
and the roune laboratory work-up
Lower limit
Upper limit
Figure 3. Tornado diagram showing the impact of changes in the most relevant input parameters on the difference in costs.
ACD: anaemia of chronic disease; GP: general practitioner; IDA: iron deficiency anaemia; RA: renal anaemia.
Figure 2. Incremental cost-effectiveness plane showing the
impact of the extensive laboratory work-up as compared with
the routine laboratory work-up on the difference in the per-
centage of correctly diagnosed underlying causes of anaemia, as
well as the difference in costs per patient, for 10,000 model
simulations.
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increase in costs of E3/patient (þ0.3%) was expected.
Whereas the improvement in diagnosis was quite
likely (chance of an increase in correct diagnosis
equals 6.4%), the exact eﬀect of this extensive work-
up on the changes in costs was quite uncertain
(chance that the extensive work-up would actually
save costs equals 44.2%). Although higher costs were
expected among IDA and ACD patients, most cost-
savings were expected to be achieved among patients
with renal and ‘other’ types of anaemia.
Despite the probable increase of 6.4% in correct
diagnoses, the results varied considerably between the
diﬀerent underlying causes of anaemia. The largest
improvements in this probability were expected in
ACD and renal anaemia patients (i.e. þ10.1% and
þ12.4%, respectively). However, costs of referrals
were expected to increase by E47/patient among
ACD patients, whereas those costs decreased by E59/
patient among renal anaemia patients. The increase in
costs among ACD patients was explained by the higher
immediate referral rate to secondary care (i.e. referral
following the initialGP consultation) after the extensive
work-up rather than after the routine work-up (38% vs.
26%), while the probability of follow-up was lower
(48% vs. 60%). As the probability of spontaneous
recovery among ACD patients was estimated to be rela-
tively high (i.e. 38%), higher referral rates lead to
higher costs in the extensive work-up in this patient
category. Combined with the relatively high frequency
of ACD (32% of all newly diagnosed anaemia patients
in general practice), this may strongly impact the over-
all costs. Therefore, eﬀort should be spent on deciding
which patient management strategy (i.e. referral or
follow-up) results in most improvements in the patient’s
quality of life, at the lowest costs.
For renal anaemia patients, the results indicate that
42% and 48% of those patients were immediately
referred to secondary care in the routine versus the exten-
sive work-up, which was considered the only appropriate
management decision according to the expert panel
(Supplemental Data 1). Thus, besides expected improve-
ments in diagnosing renal anaemia due to the extensive
work-up, this work-up also increased the number of
patients who would immediately receive an eﬀective
management strategy, which likely decreases costs fur-
ther downstream the care pathway.
In IDA patients, the probability of a correct diagno-
sis remained almost unchanged in the extensive as com-
pared with the routine work-up (i.e. þ0.9%), while
costs increased with E28/patient. When considering
the management decisions made in those patients, it
was found that this increase in costs was mostly attrib-
utable to an expected 6% increase in immediate refer-
rals (43% vs. 37%). However, the DCGP guideline
recommends a colonoscopy and/or gastroscopy in
IDA patients aged> 50 years, to exclude a gastrointes-
tinal malignancy.24 As such malignancies can be
detected in 6–15% of IDA patients,25–30 this increase
in immediate referrals may increase the probability that
a gastrointestinal malignancy is diagnosed. Thereby,
this increase in costs will likely enhance rapid initiation
of adequate treatment, potentially improving treatment
eﬀectiveness. However, as such a referral decision
should be based on a patient’s clinical signs and symp-
toms (which were unknown in the current analysis), the
real-life impact of this extensive work-up on the diag-
nosis and treatment of gastrointestinal malignancies
remains to be investigated.
Although the previously performed eﬀectiveness
analysis distinguished only four underlying causes of
anaemia (IDA, ACD, renal anaemia and ‘other’),19 the
current study further divided the ‘other’ category into
suspected bone marrow disease, vitamin B12 or folic
acid deﬁciency and unknown causes. Subsequently,
only the remaining patients were categorized as ‘other’.
Although those additional subgroups were too small for
any demonstrable results, this subdivision allowed for a
more precise calculation on the costs of these diagnoses.
However, it is reasonable to assume that GPs are unable
to diagnose these less common causes of anaemia based
solely on laboratory test results: they often require fur-
ther diagnostic testing or referral to secondary care to
determine these causes. Therefore, in order to allow an
accurate cost estimation, the approach taken to analyse
the eﬀectiveness in the current study diﬀered slightly
from the approach taken in the previously published
article. Consequently, the results from the current
study indicate a slightly lower percentage of correctly
diagnosed underlying causes when compared with the
previous study.19
Strengths
The results are expected to provide a good representa-
tion of the Dutch population aged5 50 years with
newly diagnosed anaemia in primary care, because the
cases in the survey were based on real-life patient data,
the incidence of the various causes of anaemia in the
survey correspond with their occurrence in daily prac-
tice,19 and because the participating GPs were represen-
tative of the GP population in the Netherlands.19
As 96.4% of the 10,000 model simulations indicated
that the extensive laboratory work-up would increase
the percentage of patients correctly diagnosed, this
result was robust to uncertainty in input parameters.
Of those simulations, 44.2% indicated lower total
costs with the use of an extensive work-up, although
there was an average increase of E3 per patient, over-
all, indicating that the exact impact on costs is likely
very limited but remains uncertain. However, the
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average number of tests performed in the extensive
work-up doubled those performed in the routine
work-up (14 vs. 7). That the increase in costs remains
so small can easily be explained as the costs of add-
itional diagnostic tests are oﬀset by performing all
tests during one GP visit and one phlebotomy, thereby
preventing repeated blood sampling (involving add-
itional costs of GP visits, the order tariﬀ for requesting
laboratory tests, and lost productivity among patients).
This is also conﬁrmed by the results, as 55.4% of 10,000
model simulations indicated that the costs of diagnostic
testing at the GP were actually lower in the extensive
work-up.
Limitations
This study has certain limitations. First, as described
previously,19 the GPs were not provided with the
patient’s anamnesis, medical history and physical
examination. It is therefore likely that the accuracy of
the diagnoses of the responding GPs may be higher in
real-life. Although this limitation was present in all
cases within the study, their potential eﬀect on the dif-
ferences between the two analysis methods is most
likely limited, although it cannot be excluded that the
abovementioned patient characteristics may have
aﬀected the tests that would have been requested by
the GPs. Furthermore, it is uncertain to what extent
GPs’ diagnostic and treatment decisions in the survey
may diﬀer from real life.
Secondly, as mentioned previously, the costs of treat-
ing anaemia in secondary care have not been included in
the model because of large diﬀerences in treatments for
the diﬀerent underlying causes and the lack of patient-
level data. However, a delayed correct diagnosis likely
delays the initiation of adequate treatment, negatively
aﬀects quality of life3 and potentially increases treatment
costs owing to an increased severity of anaemia.
Therefore, it was conservatively assumed that costs
after establishing the correct diagnosis will not diﬀer
between patients. Consequently, current results are
likely an underestimation of the potential additional
beneﬁts provided by the extensive laboratory work-up.
Third, as information for some model input param-
eters could not be obtained from literature, expert esti-
mates had to be used. Although the number of experts
was limited (n¼ 2), the results of probabilistic
(Supplemental Data 1) and one-way sensitivity analyses
indicated that the impact of changes in model param-
eters (as based on those expert elicitations) on model
outcomes was limited.
Fourth, in the Netherlands, 64% of the clinical
chemistry laboratories oﬀer reﬂex testing.31 In reﬂex
testing, GPs do not decide themselves which laboratory
tests to perform in suspected anaemia patients, but
instead request ‘anaemia analysis’. The laboratory will
then perform a predeﬁned set of tests, and sequentially
perform additional tests if the initial tests indicate the
presence of anaemia.31 In addition, 27% of these
laboratories provide an interpretative comment along
with the test result.31 As this reﬂex testing could not be
incorporated in the current study, the proportion of
patients correctly diagnosed in current clinical practice
(reﬂected by the routine work-up) may be underesti-
mated. However, the set of tests performed in reﬂex
testing diﬀers strongly between laboratories31 and
often involves fewer diagnostic tests compared with
the extensive work-up presented in the current study.
In addition, although the DCGP -guidelines recom-
mend reﬂex testing in patients with newly diagnosed
anaemia,24 it is not yet oﬀered by all laboratories and
can therefore not yet be considered common practice
among GPs. Thus, although the added beneﬁt of the
extensive work-up may be slightly overestimated in the
current analysis, it likely still increases the number of
patients for whom the underlying cause is correctly
diagnosed by the GP. Furthermore, the insights
obtained from this study are likely of added value to
decide upon the optimal combination of tests to be used
for reﬂex testing, which may increase similarity in diag-
nostic work-ups between laboratories.
Implications for practice
As subgroup analyses revealed that the added value of
the extensive laboratory work-up depends on the
underlying cause of anaemia, further research into
this variation is recommended. Which tests contribute
most to establishing the correct underlying cause
should be investigated, in order to select a laboratory
work-up that can correctly diagnose the majority of
patients with minimal inconvenience (i.e. multiple veni-
punctures) and at minimal costs.
Transferability of these results to other countries is
not straightforward, as the work-up regarding the diag-
nosis of anaemia patients and the attributed costs may
vary greatly between countries. Populating the model
with country-speciﬁc data would support reliable coun-
try-speciﬁc estimations of the cost-eﬀectiveness of both
work-ups.
In conclusion, although the extensive laboratory
work-up is usually more eﬀective for diagnosing the
underlying cause of anaemia by GPs, it is not always
more cost-eﬀective than the routine work-up.
Nevertheless, the impact on costs was found to be min-
imal. Given that the extensive work-up results in add-
itional beneﬁts which could not be captured in the
current analysis (i.e. in terms of a faster diagnosis
which may improve a patient’s quality of life, and
reduced productivity losses among anaemia patients
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and their caregivers), using an extensive laboratory
work-up is expected to be cost-eﬀective.
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